Electronegative LDL impairs vascular endothelial cell integrity in diabetes by disrupting fibroblast growth factor 2 (FGF2) autoregulation

Diabetes

Volumn 57, Issue 1, 2008, Pages 158-166

  Lu, Jonathan ^a   Jiang, Wei ^a,b   Yang, Jun Hai ^a   Chang, Po Yuan ^c   Walterscheid, Jeffrey P ^a   Chen, Hsin Hung ^a   Marcelli, Marco ^a   Tang, Daming ^a   Lee, Yuan Teh ^c   Liao, Warren S L ^b   Yang, Chao Yuh ^a   Chen, Chu Huang ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; COMPLEMENTARY DNA; FIBROBLAST GROWTH FACTOR 2; LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; VASCULOTROPIN; WORTMANNIN; OXIDIZED LOW DENSITY LIPOPROTEIN; VASCULOTROPIN A;

ANIMAL CELL; ARTICLE; AUTOREGULATION; CELL CULTURE; CELL ISOLATION; CELL SURVIVAL; CONTROLLED STUDY; DRUG INHIBITION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE CONTROL; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; VASCULAR ENDOTHELIUM; WESTERN BLOTTING; ANIMAL; AORTA; APOPTOSIS; BLOOD; CATTLE; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION; HOMEOSTASIS; ISOLATION AND PURIFICATION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REFERENCE VALUE;

ANIMALS; AORTA; APOPTOSIS; CATTLE; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM, VASCULAR; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION; HOMEOSTASIS; HUMANS; LIPOPROTEINS, LDL; REFERENCE VALUES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 38449095405     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db07-1287     Document Type: Article

References (40)

1. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ: Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Arterioscler Thromb Vasc Biol 24:e149-e161, 2004
2. Nesto RW: Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome. Am J Cardiovasc Drugs 5:379-387, 2005
3. Chen CH, Jiang T, Yang JH, Jiang W, Lu J, Marathe GK, Pownall HJ, Ballantyne CM, McIntyre TM, Henry PD, Yang CY: Low-density lipoprotein in HC human plasma induces vascular endothelial cell apoptosis by inhibiting fibroblast growth factor 2 transcription. Circulation 107:2102-2108, 2003
4. Yang CY, Raya JL, Chen HH, Chen CH, Abe Y, Pownall HJ, Taylor AA, Smith CV: Isolation, characterization, and functional assessment of oxidatively modified subfractions of circulating low-density lipoproteins. Arterioscler Thromb Vasc Biol 23:1083-1090, 2003
5. Tai MH, Kuo SM, Liang HT, Chiou KR, Lam HC, Hsu CM, Pownall HJ, Chen HH, Huang MT, Yang CY: Modulation of angiogenic processes in cultured endothelial cells by low density lipoproteins subfractions from patients with familial hypercholesterolemia. Atherosclerosis 186:448-457, 2006
6. Avogaro P, Bon GB, Cazzolato G: Presence of a modified low density lipoprotein in humans. Arteriosclerosis 8:79-87, 1988
7. Demuth K, Myara I, Chappey B, Vedie B, Pech-Amsellem MA, Haberland ME, Moatti N: A cytotoxic electronegative LDL subfraction is present in human plasma. Arterioscler Thromb Vasc Biol 16:773-783, 1996
8. Ziouzenkova O, Asatryan L, Sahady D, Orasanu G, Perrey S, Cutak B, Hassell T, Akiyama TE, Berger JP, Sevanian A, Plutzky J: Dual roles for lipolysis and oxidation in peroxisome proliferation-activator receptor responses to electronegative low density lipoprotein. J Biol Chem 278:39874-39881, 2003
9. Benitez S, Sanchez-Quesada JL, Ribas V, Jorba O, Blanco-Vaca F, Gonzalez-Sastre F, Ordonez-Llanos J: Platelet-activating factor acetylhydrolase is mainly associated with electronegative low-density lipoprotein subfraction. Circulation 108:92-96, 2003
10. Sanchez-Quesada JL, Benitez S, Ordonez-Llanos J: Electronegative low-density lipoprotein. Curr Opin Lipidol 15:329-335, 2004
11. Asatryan L, Hamilton RT, Isas JM, Hwang J, Kayed R, Sevanian A: LDL phospholipid hydrolysis produces modified electronegative particles with an unfolded apoB-100 protein. J Lipid Res 46:115-122, 2005
12. Guevara NV, Chen KH, Chan L: Apoptosis in atherosclerosis: pathological and pharmacological implications. Pharmacol Res 44:59-71, 2001
13. Choy JC, Granville DJ, Hunt DW, McManus BM: Endothelial cell apoptosis: biochemical characteristics and potential implications for atherosclerosis. J Mol Cell Cardiol 33:1673-1690, 2001
14. Rigla M, Sanchez-Quesada JL, Ordonez-Llanos J, Prat T, Caixas A, Jorba O, Serra JR, de Leiva A, Perez A: Effect of physical exercise on lipoprotein(a) and low-density lipoprotein modifications in type 1 and type 2 diabetic patients. Metabolism 49:640-647, 2000
15. Yang CH, Chen HH, Huang MT, Raya JL, Yang JH, Chen CH, Gaubatz JW, Pownall HJ, Taylor AA, Ballantyne CM, Jenniskens FA, Smith CV: Proapoptotic low-density lipoprotein subfractions in type II diabetes atherosclerosis. Atherosclerosis 193:283-291, 2007
16. Klagsbrun M, Edelman ER: Biological and biochemical properties of fibroblast growth factors: implications for the pathogenesis of atherosclerosis. Arteriosclerosis 9:269-278, 1989
17. Chen CH, Poucher SM, Lu J, Henry PD: Fibroblast growth factor 2: from laboratory evidence to clinical application. Curr Vasc Pharmacol 2:33-43, 2004
18. Folkman J, Klagsbrun M, Sasse J, Wadzinski M, Ingber D, Vlodavsky I: A heparin-binding angiogenic protein- basic fibroblast growth factor-is stored within basement membrane. Am J Pathol 130:393-400, 1988
19. Heil M, Schaper W: Influence of mechanical, cellular, and molecular factors on collateral artery growth (arteriogenesis). Circ Res 95:449-458, 2004
20. Chen CH, Walterscheid JP: Plaque angiogenesis versus compensatory arteriogenesis in atherosclerosis. Circ Res 99:787-789, 2006
21. Bochkov VN, Philippova M, Oskolkova O, Kadl A, Furnkranz A, Karabeg A, Afonyushkin T, Gruber F, Breuss J, Minchenko A, Mechtcheriakova D, Hohensinner P, Rychli K, Wojta J, Resink T, Erne P, Binder BR, Leitinger N: Oxidized phospholipids stimulate angiogenesis via autocrine mechanisms implicating a novel role for lipid oxidation in the evolution of atherosclerotic lesions. Circ Res 99:900-908, 2006
22. Kanda S, Hodgkin MN, Woodfield RJ, Wakelam MJ, Thomas G, Claesson-Welsh L: Phosphatidylinositol 3′-kinase-independent p70 S6 kinase activation by fibroblast growth factor receptor-1 is important for proliferation but not differentiation of endothelial cells. J Biol Chem 272:23347-23353, 1997
23. Gratton JP, Morales-Ruiz M, Kureishi Y, Fulton D, Walsh K, Sessa WC: Akt down-regulation of p38 signaling provides a novel mechanism of vascular endothelial growth factor-mediated cytoprotection in endothelial cells. J Biol Chem 27:30359-30365, 2001
24. Rommel C, Clarke BA, Zimmermann S, Nunez L, Rossman R, Reid K, Moelling K, Yancopoulos GD, Glass DJ: Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. Science 286:1738-1741, 1999
25. Chavakis E, Dernbach E, Hermann C, Mondorf UF, Zeiher AM, Dimmeler S: Oxidized LDL inhibits vascular endothelial growth factor-induced endothelial cell migration by an inhibitory effect on the Akt/endothelial nitric oxide synthase pathway. Circulation 103:2102-2107, 2001
26. Abid MR, Guo S, Minami T, Spokes KC, Ueki K, Skurk C, Walsh K, Aird WC: Vascular endothelial growth factor activates PI3K/Akt/forkhead signaling in endothelial cells. Arterioscler Thromb Vasc Biol 24:294-300, 2004
27. Trivier E, Kurz DJ, Hong Y, Huang HL, Erusalimsky JD: Differential regulation of telomerase in endothelial cells by fibroblast growth factor-2 and vascular endothelial growth factor-a: association with replicative life span. Ann N Y Acad Sci 1019:111-115, 2004
28. Chang PY, Luo S, Jiang T, Lee YT, Lu SC, Henry PD, Chen CH: Oxidized low-density lipoprotein downregulates endothelial basic fibroblast growth factor through a pertussis toxin-sensitive G-protein pathway: mediator role of platelet-activating factor-like phospholipids. Circulation 104:588-593, 2001
29. Karsan A, Yee E, Poirier GG, Zhou P, Craig R, Harlan JM: Fibroblast growth factor-2 inhibits endothelial cell apoptosis by Bcl-2-dependent and independent mechanisms. Am J Pathol 151:1775-1784, 1997
30. Kumar P, Miller AI, Polverini PJ: p38 MAPK mediates gamma-irradiation- induced endothelial cell apoptosis, and vascular endothelial growth factor protects endothelial cells through the phosphoinositide 3-kinase-Akt-Bcl-2 pathway. J Biol Chem 279:43352-43360, 2004
31. Raffioni S, Bradshaw RA: Activation of phosphatidylinositol 3-kinase by epidermal growth factor, basic fibroblast growth factor, and nerve growth factor in PC12 pheochromocytoma cells. Proc Natl Acad Sci U S A 89:9121-9125, 1992
32. Dimmeler S, Haendeler J, Galle J, Zeiher AM: Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases: a mechanistic clue to the 'response to injury' hypothesis. Circulation 95:1760-1763, 1997
33. Tricot O, Mallat Z, Heymes C, Belmin J, Leseche G, Tedgui A: Relation between endothelial cell apoptosis and blood flow direction in human atherosclerotic plaques. Circulation 101:2450-2453, 2000
34. Mallat Z, Benamer H, Hugel B, Benessiano J, Steg PG, Freyssinet JM, Tedgui A: Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 101:841-843, 2000
35. Steinberg D, Witztum JL: Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis? Circulation 105:2107-2111, 2002
36. Damasceno NR, Sevanian A, Apolinario E, Oliveira JM, Fernandes I, Abdalla DS: Detection of electronegative low density lipoprotein (LDL(-)) in plasma and atherosclerotic lesions by monoclonal antibody-based immunoassays. Clin Biochem 39:28-38, 2006
37. Subbanagounder G, Leitinger N, Schwenke DC, Wong JW, Lee H, Rizza C, Watson AD, Faull KF, Fogelman AM, Berliner JA: Determinants of bioactivity of oxidized phospholipids: specific oxidized fatty acyl groups at the sn-2 position. Arterioscler Thromb Vasc Biol 20:2248-2254, 2000
38. Chaudhary LR, Hruska KA: The cell survival signal Akt is differentially activated by PDGF-BB, EGF, and FGF-2 in osteoblastic cells. J Cell Biochem 81:304-311, 2001
39. Seghezzi G, Patel S, Ren CJ, Gualandris A, Pintucci G, Robbins ES, Shapiro RL, Galloway AC, Rifkin DB, Mignatti P: Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis. J Cell Biol 141:1659-1673, 1998
40. Ferby IM, Waga I, Hoshino M, Kume K, Shimizu T: Wortmannin inhibits mitogen-activated protein kinase activation by platelet-activating factor through a mechanism independent of p85/p110-type phosphatidylinositol 3-kinase. J Biol Chem 271:11684-11688, 1996